21-44509263-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144991.3(TSPEAR):c.1690G>A(p.Val564Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.1690G>A | p.Val564Ile | missense_variant | 10/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR-AS1 | NR_103707.1 | n.1226C>T | non_coding_transcript_exon_variant | 5/7 | ||||
TSPEAR | NM_001272037.2 | c.1486G>A | p.Val496Ile | missense_variant | 11/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.1690G>A | p.Val564Ile | missense_variant | 10/12 | 1 | NM_144991.3 | ENSP00000321987 | P1 | |
TSPEAR | ENST00000397916.1 | n.1645G>A | non_coding_transcript_exon_variant | 10/11 | 1 | |||||
TSPEAR-AS1 | ENST00000451035.2 | n.781C>T | non_coding_transcript_exon_variant | 4/6 | 5 | |||||
TSPEAR | ENST00000642437.1 | c.*1635G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | ENSP00000496535 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152060Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251352Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135878
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461842Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727218
GnomAD4 genome AF: 0.000112 AC: 17AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74382
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 564 of the TSPEAR protein (p.Val564Ile). This variant is present in population databases (rs150792705, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TSPEAR-related conditions. ClinVar contains an entry for this variant (Variation ID: 504868). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TSPEAR protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2021 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 24, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Val564Ile var iant in TSPEAR has not been previously reported in individuals with hearing loss , but has been identified in several populations by the Exome Aggregation Consor tium including 4/10346 African chromosomes (ExAC, http://exac.broadinstitute.org ; dbSNP rs150792705). However, its frequency is not high enough to rule out a pa thogenic role. Computational prediction tools and conservation analysis suggest that the p.Val564Ile variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clini cal significance of the p.Val564Ile variant is uncertain, the computational and conservation data suggest it is more likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at